Unknown

Dataset Information

0

Rare variant phasing using paired tumor:normal sequence data.


ABSTRACT: BACKGROUND:In standard high throughput sequencing analysis, genetic variants are not assigned to a homologous chromosome of origin. This process, called haplotype phasing, can reveal information important for understanding the relationship between genetic variants and biological phenotypes. For example, in genes that carry multiple heterozygous missense variants, phasing resolves whether one or both gene copies are altered. Here, we present a novel approach to phasing variants that takes advantage of unique properties of paired tumor:normal sequencing data from cancer studies. RESULTS:VAF phasing uses changes in variant allele frequency (VAF) between tumor and normal samples in regions of somatic chromosomal gain or loss to phase germline variants. We apply VAF phasing to 6180 samples from the Cancer Genome Atlas (TCGA) and demonstrate that our method is highly concordant with other standard phasing methods, and can phase an average of 33% more variants than other read-backed phasing methods. Using variant annotation tools designed to score gene haplotypes, we find a suggestive association between carrying multiple missense variants in a single copy of a cancer predisposition gene and earlier age of cancer diagnosis. CONCLUSIONS:VAF phasing exploits unique properties of tumor genomes to increase the number of germline variants that can be phased over standard read-backed methods in paired tumor:normal samples. Our phase-informed association testing results call attention to the need to develop more tools for assessing the joint effect of multiple genetic variants.

SUBMITTER: Buckley AR 

PROVIDER: S-EPMC6537421 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6609817 | BioStudies
1000-01-01 | S-EPMC5680209 | BioStudies
2020-01-01 | S-EPMC7259889 | BioStudies
2020-01-01 | S-EPMC6918881 | BioStudies
2019-01-01 | S-EPMC6900933 | BioStudies
2020-01-01 | S-EPMC7065972 | BioStudies
2020-01-01 | S-EPMC7605438 | BioStudies
2015-01-01 | S-EPMC6218178 | BioStudies
2018-01-01 | S-EPMC5880258 | BioStudies
2018-01-01 | S-EPMC6116990 | BioStudies